Kairos Pharma, Ltd.(KAPA)
$0.45-0.03 (-5.63%)
KAPA
Kairos Pharma, Ltd. financials statements
$0.45
At close:-0.03 (-5.63%)
Kairos Pharma, Ltd. (KAPA) Income Statement
180 Followers
Kairos Pharma, Ltd. Income Statement
Last quarter (Q3 2026), Kairos Pharma, Ltd.'s total revenue was $0.00. In Q3, Kairos Pharma, Ltd.'s net income was $-1.98M. See Kairos Pharma, Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -160.00K | $ -160.00K | $ -160.00K | $ -98.00K | |
| $ 5.57M | $ 2.18M | $ 1.55M | $ 411.00K | $ 1.84M | |
| Depreciation and Amortization | $ 160.00K | $ 160.00K | $ 160.00K | $ 160.00K | $ 98.00K |
| $ -5.29M | $ -1.58M | $ -1.55M | $ -411.00K | $ -1.84M | |
| $ -5.57M | $ -2.34M | $ -1.71M | $ -571.00K | $ -1.94M | |
| $ 125.00K | $ -260.00K | $ -98.00K | $ -479.00K | $ -202.00K | |
| $ -5.45M | $ -2.60M | $ -1.81M | $ -1.05M | $ -2.15M | |
| $ -5.45M | $ -2.60M | $ -1.81M | $ -1.05M | $ -2.15M | |
| Per Share Metrics | |||||
| Basic EPS | $ -2.10 | $ -1.61 | $ -1.19 | $ -0.70 | $ -1.19 |
| Diluted EPS | $ -2.10 | $ -1.61 | $ -1.19 | $ -0.70 | $ -1.19 |
| Weighted Average Shares Outstanding | 2.63M | 1.62M | 1.48M | 1.46M | 1.83M |
| Weighted Average Shares Outstanding (Diluted) | 2.63M | 1.62M | 1.48M | 1.46M | 1.83M |
Currency in USD

